Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that primarily affects the lungs and causes coronavirus disease 2019 (COVID-19). Recent clinical cases have reported the cardiovascular complications of COVID-19, including myocarditis, arrhythmia, myocardial infarction, and so on. Among them, COVID-19-related myocarditis exhibits diverse symptoms, which can occur at different ages and has a delayed onset. Moreover, COVID-19-related myocarditis is positively correlated with the poor prognosis and mortality of COVID-19 patients. The exploration of its clinical characteristics, potential pathogenesis and treatment may provide new ideas and strategies for the prevention and drug development of COVID-19-related myocarditis in the future. This article provides an overview of both domestic and foreign researches on COVID-19-related myocarditis.